Join the audience for a live webinar at 4 p.m. GMT/8 a.m. PST on 4 February 2027
Beyond dogma: what does the evidence say about SRS prescription isodose?
Want to take part in this webinar?
Stereotactic radiosurgery platforms have evolved around distinctly different treatment philosophies – including fundamental differences in prescription isodose selection. Dedicated radiosurgery systems have traditionally favored prescriptions near the 50% isodose line, while those that inherited principles of homogeneity from radiotherapy commonly prescribe closer to 80–90%.
But which philosophy is best supported by the evidence?
This webinar will move beyond convention and platform-specific dogma to examine what the literature tells us about prescription isodose selection and its impact on treatment quality and outcomes.…